메뉴 건너뛰기




Volumn 59, Issue 6, 2013, Pages 1264-1270

ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma

Author keywords

Early hepatocellular carcinoma; Endocan; ESM 1; Immunohistochemistry; Liver biopsy; Microvascular invasion; Radiofrequency ablation; Tissue biomarkers

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; BILIRUBIN; CYTOKERATIN 19; ENDOTHELIAL CELL SPECIFIC MOLECULE 1; EPITHELIAL CELL ADHESION MOLECULE; GLUTAMATE AMMONIA LIGASE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

EID: 84888002520     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.07.030     Document Type: Article
Times cited : (38)

References (28)
  • 1
    • 82455198589 scopus 로고    scopus 로고
    • Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
    • J.C. Trinchet, C. Chaffaut, V. Bourcier, F. Degos, J. Henrion, and H. Fontaine Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities Hepatology 54 2011 1987 1997
    • (2011) Hepatology , vol.54 , pp. 1987-1997
    • Trinchet, J.C.1    Chaffaut, C.2    Bourcier, V.3    Degos, F.4    Henrion, J.5    Fontaine, H.6
  • 2
    • 79955401037 scopus 로고    scopus 로고
    • Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
    • A. Villanueva, Y. Hoshida, C. Battiston, V. Tovar, D. Sia, and C. Alsinet Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma Gastroenterology 140 2011 e1502
    • (2011) Gastroenterology , vol.140 , pp. 1502
    • Villanueva, A.1    Hoshida, Y.2    Battiston, C.3    Tovar, V.4    Sia, D.5    Alsinet, C.6
  • 3
    • 0037308463 scopus 로고    scopus 로고
    • Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
    • H. Imamura, Y. Matsuyama, E. Tanaka, T. Ohkubo, K. Hasegawa, and S. Miyagawa Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol 38 2003 200 207
    • (2003) J Hepatol , vol.38 , pp. 200-207
    • Imamura, H.1    Matsuyama, Y.2    Tanaka, E.3    Ohkubo, T.4    Hasegawa, K.5    Miyagawa, S.6
  • 4
    • 12644304864 scopus 로고    scopus 로고
    • Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma
    • T. Kumada, S. Nakano, I. Takeda, K. Sugiyama, T. Osada, and S. Kiriyama Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma Hepatology 25 2007 87 92
    • (2007) Hepatology , vol.25 , pp. 87-92
    • Kumada, T.1    Nakano, S.2    Takeda, I.3    Sugiyama, K.4    Osada, T.5    Kiriyama, S.6
  • 5
    • 0032742183 scopus 로고    scopus 로고
    • Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
    • J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
    • (1999) Hepatology , vol.30 , pp. 1434-1440
    • Llovet, J.M.1    Fuster, J.2    Bruix, J.3
  • 6
    • 69349099400 scopus 로고    scopus 로고
    • A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma
    • S. Roayaie, I.N. Blume, S.N. Thung, M. Guido, M.I. Fiel, and S. Hiotis A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma Gastroenterology 137 2009 850 855
    • (2009) Gastroenterology , vol.137 , pp. 850-855
    • Roayaie, S.1    Blume, I.N.2    Thung, S.N.3    Guido, M.4    Fiel, M.I.5    Hiotis, S.6
  • 7
    • 44649111962 scopus 로고    scopus 로고
    • Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
    • T. Ishizawa, K. Hasegawa, T. Aoki, M. Takahashi, Y. Inoue, and K. Sano Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 2008 1908 1916
    • (2008) Gastroenterology , vol.134 , pp. 1908-1916
    • Ishizawa, T.1    Hasegawa, K.2    Aoki, T.3    Takahashi, M.4    Inoue, Y.5    Sano, K.6
  • 8
    • 59149083473 scopus 로고    scopus 로고
    • Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype
    • N. Almog, L. Ma, R. Raychowdhury, C. Schwager, R. Erber, and S. Short Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype Cancer Res 69 2009 836 844
    • (2009) Cancer Res , vol.69 , pp. 836-844
    • Almog, N.1    Ma, L.2    Raychowdhury, R.3    Schwager, C.4    Erber, R.5    Short, S.6
  • 9
    • 0035930590 scopus 로고    scopus 로고
    • Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity
    • D. Béchard, T. Gentina, M. Delehedde, A. Scherpereel, M. Lyon, and M. Aumercier Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity J Biol Chem 276 2001 48341 48349
    • (2001) J Biol Chem , vol.276 , pp. 48341-48349
    • Béchard, D.1    Gentina, T.2    Delehedde, M.3    Scherpereel, A.4    Lyon, M.5    Aumercier, M.6
  • 10
    • 73449131546 scopus 로고    scopus 로고
    • Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma
    • X. Leroy, S. Aubert, L. Zini, H. Franquet, G. Kervoaze, and A. Villers Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma Histopathology 56 2010 180 187
    • (2010) Histopathology , vol.56 , pp. 180-187
    • Leroy, X.1    Aubert, S.2    Zini, L.3    Franquet, H.4    Kervoaze, G.5    Villers, A.6
  • 11
    • 0029808101 scopus 로고    scopus 로고
    • ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines
    • P. Lassalle, S. Molet, A. Janin, J.V. Heyden, J. Tavernier, and W. Fiers ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines J Biol Chem 271 1996 20458 20464
    • (1996) J Biol Chem , vol.271 , pp. 20458-20464
    • Lassalle, P.1    Molet, S.2    Janin, A.3    Heyden, J.V.4    Tavernier, J.5    Fiers, W.6
  • 12
    • 78651053628 scopus 로고
    • Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies
    • H.A. Edmondson, and P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462 503
    • (1954) Cancer , vol.7 , pp. 462-503
    • Edmondson, H.A.1    Steiner, P.E.2
  • 13
    • 33645551138 scopus 로고    scopus 로고
    • The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin
    • A. Durnez, C. Verslype, F. Nevens, J. Fevery, R. Aerts, and J. Pirenne The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin Histopathology 49 2006 138 151
    • (2006) Histopathology , vol.49 , pp. 138-151
    • Durnez, A.1    Verslype, C.2    Nevens, F.3    Fevery, J.4    Aerts, R.5    Pirenne, J.6
  • 14
    • 77950632068 scopus 로고    scopus 로고
    • Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation
    • B. Dal Bello, L. Rosa, N. Campanini, C. Tinelli, F. Torello Viera, and G. D'Ambrosio Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation Clin Cancer Res 16 2010 2157 2166
    • (2010) Clin Cancer Res , vol.16 , pp. 2157-2166
    • Dal Bello, B.1    Rosa, L.2    Campanini, N.3    Tinelli, C.4    Torello Viera, F.5    D'Ambrosio, G.6
  • 15
    • 80052342926 scopus 로고    scopus 로고
    • Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: A systematic review
    • Y.K. Cho, H. Rhim, and S. Noh Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review J Gastroenterol Hepatol 26 2011 1354 1360
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 1354-1360
    • Cho, Y.K.1    Rhim, H.2    Noh, S.3
  • 16
    • 84866774340 scopus 로고    scopus 로고
    • Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma
    • H. van Malenstein, M. Komuta, C. Verslype, V. Vandecaveye, B. Van Calster, and B. Topal Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma Hepatol Res 42 2012 990 998
    • (2012) Hepatol Res , vol.42 , pp. 990-998
    • Van Malenstein, H.1    Komuta, M.2    Verslype, C.3    Vandecaveye, V.4    Van Calster, B.5    Topal, B.6
  • 18
    • 77953728436 scopus 로고    scopus 로고
    • Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion
    • L.Y. Chen, X. Liu, S.L. Wang, and C.Y. Qin Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion J Int Med Res 38 2010 498 510
    • (2010) J Int Med Res , vol.38 , pp. 498-510
    • Chen, L.Y.1    Liu, X.2    Wang, S.L.3    Qin, C.Y.4
  • 19
    • 59449098649 scopus 로고    scopus 로고
    • Endocan expression correlated with poor survival in human hepatocellular carcinoma
    • G.W. Huang, Y.M. Tao, and X. Ding Endocan expression correlated with poor survival in human hepatocellular carcinoma Dig Dis Sci 54 2009 389 394
    • (2009) Dig Dis Sci , vol.54 , pp. 389-394
    • Huang, G.W.1    Tao, Y.M.2    Ding, X.3
  • 20
    • 80055060696 scopus 로고    scopus 로고
    • Human hepatocellular carcinomas with "stemness"-related marker expression: Keratin 19 expression and a poor prognosis
    • H. Kim, G. Choi, D. Na, E. Ahn, G. Kim, and J. Lee Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis Hepatology 54 2011 1707 1717
    • (2011) Hepatology , vol.54 , pp. 1707-1717
    • Kim, H.1    Choi, G.2    Na, D.3    Ahn, E.4    Kim, G.5    Lee, J.6
  • 21
    • 60449087921 scopus 로고    scopus 로고
    • EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features
    • T. Yamashita, J. Ji, A. Budhu, M. Forgues, W. Yang, and H.Y. Wang EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features Gastroenterology 136 2009 1012 1024
    • (2009) Gastroenterology , vol.136 , pp. 1012-1024
    • Yamashita, T.1    Ji, J.2    Budhu, A.3    Forgues, M.4    Yang, W.5    Wang, H.Y.6
  • 22
    • 79959845312 scopus 로고    scopus 로고
    • Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation
    • K. Tsuchiya, M. Komuta, Y. Yasui, N. Tamaki, T. Hosokawa, and K. Ueda Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation Oncology 80 2011 278 288
    • (2011) Oncology , vol.80 , pp. 278-288
    • Tsuchiya, K.1    Komuta, M.2    Yasui, Y.3    Tamaki, N.4    Hosokawa, T.5    Ueda, K.6
  • 23
    • 84861978789 scopus 로고    scopus 로고
    • Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma
    • J. Bae, H. Choi, S. Noh, B. Park, K. Jang, and C. Park Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma Oncol Lett 4 2012 213 220
    • (2012) Oncol Lett , vol.4 , pp. 213-220
    • Bae, J.1    Choi, H.2    Noh, S.3    Park, B.4    Jang, K.5    Park, C.6
  • 24
    • 84979863108 scopus 로고    scopus 로고
    • Hepatocellular carcinoma enters the sequencing era
    • A. Villanueva, Y. Hoshida, and J.M. Llovet Hepatocellular carcinoma enters the sequencing era Gastroenterology 141 2011 1943 1945
    • (2011) Gastroenterology , vol.141 , pp. 1943-1945
    • Villanueva, A.1    Hoshida, Y.2    Llovet, J.M.3
  • 25
    • 40449099255 scopus 로고    scopus 로고
    • EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
    • T. Yamashita, M. Forgues, W. Wang, J.W. Kim, Q. Ye, and H. Jia EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461
    • (2008) Cancer Res , vol.68 , pp. 1451-1461
    • Yamashita, T.1    Forgues, M.2    Wang, W.3    Kim, J.W.4    Ye, Q.5    Jia, H.6
  • 26
    • 33846463379 scopus 로고    scopus 로고
    • Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
    • S. Boyault, D.S. Rickman, A. de Reynies, C. Balabaud, S. Rebouissou, and E. Jeannot Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52
    • (2007) Hepatology , vol.45 , pp. 42-52
    • Boyault, S.1    Rickman, D.S.2    De Reynies, A.3    Balabaud, C.4    Rebouissou, S.5    Jeannot, E.6
  • 27
    • 70349871321 scopus 로고    scopus 로고
    • MicroRNA expression, survival, and response to interferon in liver cancer
    • J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, and S. Roessler MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
    • (2009) N Engl J Med , vol.361 , pp. 1437-1447
    • Ji, J.1    Shi, J.2    Budhu, A.3    Yu, Z.4    Forgues, M.5    Roessler, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.